Janssen Vaccines & Prevention B.V.
CAGE Code: H1N64
NCAGE Code: H1N64
Status: Active
Type: Manufacturer
Summary
Janssen Vaccines & Prevention B.V. is an Active Manufacturer with the Cage Code H1N64.
Address
Archimedesweg 4
2048
Leiden
2333 CN
Netherlands
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
North Power Construction Company Newyork Eagle Construction Company Super Jet Group Sina Aria Logistic And Trading Arif Noor Construction Company,Ltd Melad Abrar Intl. Transit And Bashir Qayum Logistics Services Dostamani Construction Company Sayed Zawar Ali Khan Renewable Energy Agency Jlcc Mohammad Eisa Sardarzada Well Naweed Insaaf Construction Company Aria Roshan Trading Company Inc Abdul Waris Kamran Road And Priority Development Stratigic Co Ace Limited Liability Company Asct Group Seroosh Services Lux Star Construction Company
Frequently Asked Questions (FAQ) for CAGE H1N64
- What is CAGE Code H1N64?
- H1N64 is the unique identifier used by NATO Organizations to reference the physical entity known as Janssen Vaccines & Prevention B.V. located at Archimedesweg 4, 2048, Leiden, 2333 CN, Netherlands.
- Who is CAGE Code H1N64?
- H1N64 refers to Janssen Vaccines & Prevention B.V. located at Archimedesweg 4, 2048, Leiden, 2333 CN, Netherlands.
- Where is CAGE Code H1N64 Located?
- CAGE Code H1N64 is located in Leiden, Netherlands.
Contracting History for CAGE H1N64 Most Recent 25 Records
- HHSN272200800056C
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- 12 Sep 2018
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $76,122,958.12
- Department Of Health And Human Services (Hhs)
- HHSN272200800056C
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- 8 Aug 2023
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $69,856,435.90
- Department Of Health And Human Services (Hhs)
- HHSO100201500008C
- Nce To Extend Pop To 9/14/2020
- 25 Nov 2019
- Nce To Extend Pop To 9/14/2020
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $49,551,141.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700013C
- Remove Hhsar Clause 352.232-71 - Electronic Submission Of Payment Requests
- 23 Jun 2022
- Remove Hhsar Clause 352.232-71 - Electronic Submission Of Payment Requests
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $132,282,550.00
- Department Of Health And Human Services (Hhs)
- HHSN272200800056C
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- 19 Sep 2018
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $75,773,118.58
- Department Of Health And Human Services (Hhs)
- HHSN272200800056C
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- 13 Sep 2023
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $69,856,435.90
- Department Of Health And Human Services (Hhs)
- HHSN272200800056C
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- 5 Sep 2019
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $74,402,221.58
- Department Of Health And Human Services (Hhs)
- HHSN272200800056C
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- 22 Jul 2019
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $74,767,730.77
- Department Of Health And Human Services (Hhs)
- HHSO100201500008C
- Mod Will Provide A No Cost Extension (Nce) For 8 Months For Clin0001 Due To The Delay Of Material Availability For Repeating The Formulation Robustness Study Under Task 1.1.3.1, Which Will Impact The Overall Timelines Of The Study For Clin0001. T
- 11 Mar 2021
- Mod Will Provide A No Cost Extension (Nce) For 8 Months For Clin0001 Due To The Delay Of Material Availability For Repeating The Formulation Robustness Study Under Task 1.1.3.1, Which Will Impact The Overall Timelines Of The Study For Clin0001. T
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $49,551,141.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700013C
- Igf::Ot::Igf
- 25 Jul 2018
- Igf::Ot::Igf
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $123,107,803.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700013C
- The Purpose Of Modification 2 Is To Additional Funds To Clin 0004. These Funds Will Be Used For The Preparation Of Datasets, Analyses And Clinical Study Reports From Studies Ebl2004 (Prevac) And Ebl2009 (Uganda) Per Request Of Fda.
- 6 Apr 2020
- The Purpose Of Modification 2 Is To Additional Funds To Clin 0004. These Funds Will Be Used For The Preparation Of Datasets, Analyses And Clinical Study Reports From Studies Ebl2004 (Prevac) And Ebl2009 (Uganda) Per Request Of Fda.
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $125,333,969.00
- Department Of Health And Human Services (Hhs)
- HHSO100201500008C
- Nce To Extend Pop To 3/14/2021
- 14 Sep 2020
- Nce To Extend Pop To 3/14/2021
- Office Of Acq&Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $49,551,141.00
- Department Of Health And Human Services (Hhs)
- HHSN272200800056C
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- 25 Aug 2022
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $70,299,100.90
- Department Of Health And Human Services (Hhs)
- HHSO100201700013C
- The Purpose Of This Modification Is To Extend The Period Of Performance For The Base Period, Option Period 2 And Option Period 3.
- 14 Sep 2023
- The Purpose Of This Modification Is To Extend The Period Of Performance For The Base Period, Option Period 2 And Option Period 3.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $132,282,550.00
- Department Of Health And Human Services (Hhs)
- HHSN272200800056C
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- 16 Sep 2021
- Advanced Development Of Multivalent Filovirus (Ebola And Marburg) Hemorrhagic Fever Vaccines
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $69,687,474.29
- Department Of Health And Human Services (Hhs)
- HHSO100201700013C
- Incorporate Technical Changes To Sow; Clin0001, Clin0004 And Clin0005 And Add Hhsar Clause 352.232-71 - Electronic Submission Of Payment Requests
- 8 Apr 2022
- Incorporate Technical Changes To Sow; Clin0001, Clin0004 And Clin0005 And Add Hhsar Clause 352.232-71 - Electronic Submission Of Payment Requests
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $132,282,550.00
- Department Of Health And Human Services (Hhs)
- HHSO100201700013C
- Janssen Will Conduct Development Activities Necessary To Achieve Licensure Of The Vaccine And Manufacture And Fill/Finish Vaccine To Be Stored As Vendor Managed Inventory (Vmi) Or Delivered To The Strategic National Stockpile (Sns). The Contract Opti
- 5 Mar 2021
- Janssen Will Conduct Development Activities Necessary To Achieve Licensure Of The Vaccine And Manufacture And Fill/Finish Vaccine To Be Stored As Vendor Managed Inventory (Vmi) Or Delivered To The Strategic National Stockpile (Sns). The Contract Opti
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $132,282,550.00
- Department Of Health And Human Services (Hhs)
- HHSO100201500008C
- Upstream And Downstream Process Development Activities For Ad26.Zebov
- 24 Jul 2019
- Upstream And Downstream Process Development Activities For Ad26.Zebov
- Office Of Acq Mgmt Policy
- Department Of Health And Human Services (Hhs)
- $49,551,141.00
- Department Of Health And Human Services (Hhs)